Characteristics of TraceTogether Users

In this protocol, we seek the understand the demographics of individuals who have used the TraceTogether mobile application. Little is known about the group of individuals who are more likely to utilise the application. Hence, this study hopes to: (1) Understand the demographics of Singaporeans who use and do not use TraceTogether, (2) Identify other behavioural habits of people who do use TraceTogether, (3) Determine if confidence in government would have any effect on TraceTogether usage

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

21 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Yale NUS

Singapore

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

At least 21 years
Has stayed in Singapore for at least 2 years

Exclusion criteria

Below 21 years
Has stayed in Singapore for less than 2 years

Treatment and study plan

Use of mobile application

Behavioral

Use of the TraceTogether mobile application during the COVID-19 period

Primary outcomes

Demographic information

Time frame: Once during initial enrolment

Age, gender, social economic status

Sponsors and collaborators

Lead sponsor

Yale-NUS College

Other

Registry information

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jul 13, 2020
Registry last updated: Dec 19, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed